Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google.

In the 2025 State of the Bible study, American Bible Society homed in on issues of identity among Americans, because research ...

In a year defined by gold’s surge and a shift in sentiment, 31 ASX mining stocks graduated from junior hopefuls to $500m-plus ...

From The Dome’s opening to Pharrell’s new Virginia brand, here’s a look at some of the biggest stories in local arts and ...

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) ...

EST Ultragenyx (RARE) sinks 42% to $19.97 after osteogenesis study misses Published first on TheFly – the ultimate source for real-time, ...

A new model rectifies the long-standing deficiencies of the electronegativity concept.

We located our favorite statues and asked our children to identify them and their significance. After a few minutes, they ...

Anecdotal stories suggesting that weight-loss drugs can help people shake long-standing addictions have been spreading fast ...

Early Mars seems to have had a protective atmosphere and liquid water in the form of oceans, rivers, and lakes. It may also ...